Provided by Tiger Fintech (Singapore) Pte. Ltd.

Brookfield Real Assets Income Fund Inc.

13.10
-0.0100-0.08%
Post-market: 13.08-0.0200-0.15%18:50 EDT
Volume:220.58K
Turnover:2.89M
Market Cap:724.18M
PE:-8.09
High:13.14
Open:13.13
Low:13.09
Close:13.11
Loading ...

Strength Seen in Exagen (XGN): Can Its 29.4% Jump Turn into More Strength?

Zacks
·
05 Feb

AgEagle Aerial Systems Participated in the French Army’s 61st Artillery Regiment Event FID25-61e RA Chaumont

GlobeNewswire
·
04 Feb

Brookfield Real Assets Income Fund Inc. Announces Quarterly Webcast

GlobeNewswire
·
04 Feb

Regional SA de Cv (MEX:RA) Q4 2024 Earnings Call Highlights: Strong Loan Growth and Strategic ...

GuruFocus.com
·
31 Jan

Veru Announces Positive Topline Data from Phase 2b QUALITY Clinical Study: Enobosarm Preserved Lean Mass in Patients Receiving WEGOVY® (Semaglutide) for Weight Reduction

GlobeNewswire
·
27 Jan

CPF closes Special Accounts for members aged 55 years and above

Felicia Tan
·
19 Jan

Spyre Therapeutics Highlights 2025 Priorities and Robust Pipeline of Upcoming Clinical Readouts

PR Newswire
·
13 Jan

Press Release: Exagen Inc. Secures Conditional NY State Approval for New Lupus and Rheumatoid Arthritis Biomarkers and Announces Select Preliminary 2024 Financial Results

Dow Jones
·
13 Jan

Press Release: RheumaGen, Inc. Launches with $15 Million Series A Financing to Advance a New Class of HLA Gene-Editing Therapies for Major Autoimmune Diseases

Dow Jones
·
09 Jan

Brookfield Real Assets Income Fund Inc. Declares Q1 2025 Distribution Schedule

GlobeNewswire
·
28 Dec 2024

Press Release: RA Capital Management Announces Close of $1.4 Billion Acquisition of Aliada Therapeutics by AbbVie

Dow Jones
·
12 Dec 2024

Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE® CTD Platform

GlobeNewswire
·
15 Nov 2024

Incannex Healthcare Inc. Reports Fiscal First Quarter 2025 Financial Results and Business Updates

GlobeNewswire
·
15 Nov 2024

Cullinan Therapeutics Announces Preclinical Data for CLN-978, a CD19-directed T Cell Engager, to be Presented at ACR Convergence 2024

GlobeNewswire
·
14 Nov 2024

Poseida Therapeutics Hosts Cell Therapy R&D Day Highlighting Its Innovative Clinical and Preclinical Pipeline

PR Newswire
·
14 Nov 2024

OmniAb Reports Third Quarter 2024 Financial Results and Business Highlights

Business Wire
·
13 Nov 2024